Cathepsin K expression and activity in canine osteosarcoma.

Area of Science:

• Oncology
• Biochemistry
• Veterinary Medicine

Background:

• Cathepsin K (CatK) is a protease secreted by osteoclasts, crucial for degrading bone matrix.
• Elevated circulating CatK levels are observed in conditions involving pathological bone resorption.

Purpose of the Study:

• To investigate the presence and inducibility of CatK in canine osteosarcoma (OS) cells.
• To determine if circulating CatK concentrations are elevated in dogs with OS and correlate with bone resorption.
• To assess CatK as a potential biomarker for monitoring treatment response in canine OS.

Main Methods:

• Analysis of CatK mRNA and protein expression in canine OS cells.
• In vitro assessment of CatK secretion and collagenolytic activity.
• Quantification of serum CatK concentrations in healthy dogs and dogs with OS.
• Evaluation of CatK levels in dogs with OS undergoing palliative radiation and antiresorptive therapy.

Main Results:

• Canine OS cells were found to contain preformed CatK in cytoplasmic vesicles.
• Transforming growth factor beta 1 (TGFβ1) induced CatK secretion from OS cells, leading to type I collagen degradation.
• Dogs with OS exhibited significantly higher serum CatK concentrations compared to healthy controls.
• Serum CatK levels decreased significantly in dogs with OS following palliative radiation and antiresorptive treatment.

Conclusions:

• Canine osteosarcoma is linked to pathological bone resorption mediated by CatK.
• CatK plays a significant role in the bone degradation associated with canine OS.
• Cathepsin K inhibitors show potential as a therapeutic strategy for managing malignant osteolysis in canine OS.